Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

India faces a challenging global economic outlook for 2026-27. Geopolitical tensions and volatile oil prices are key concerns. However, Ind...

Guardant Health is set to introduce a groundbreaking blood test in India for early cancer detection. This multi-cancer test, co-marketed by...

India Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...

With its 2026 Union Budget, India places a spotlight on the future of healthcare, specifically targeting biologics and biosimilars. A visio...

Union Budget 2026: With the announcement of the 'Biopharma Shakti' initiative, India is gearing up to take the world stage in biopharmaceut...

Finance Minister Nirmala Sitharaman announced plans for five regional medical tourism hubs. A Rs 10,000 crore Biopharma Shakti program will...

The proposed fund aims to position India as a global biopharma manufacturing hub

The joint report by the USA India Chamber of Commerce & PwC India titled, “Clinical Trial opportunities in India” which will be released at...

NITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Dru...

Ahead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...

New Delhi, June 30 (IANS) The National Biopharma Mission aimed at accelerating biopharmaceutical development in the country was launched by...

"India has a strong potential to become a hub for bio-pharma innovation and play a leading role in collaborative research for the same."

This will have a huge economic impact creating high paying jobs, intellectual property and the real possibility for India to play a leading...

India's bio-pharma sector may see a surge in R&D spending to about $25 billion in the next 15 years, according to a Boston Consulting Group...